2
UCSF Comprehensive Cancer Center and Dept. of Laboratory Medicine, San Francisco, California 94143, USA. jgray@cc.ucsf.edu
3
Cancer Research UK Department of Oncology, Hutchison/MRC Research Centre, Hills Road, Cambridge CB2 2XZ, UK. bajp@mole.bio.cam.ac.uk
The past decade has seen great strides in our understanding of the genetic basis of human disease. Arguably, the most profound impact has been in the area of cancer genetics, where the explosion of genomic sequence and molecular profiling data has illustrated the complexity of human malignancies. In a tumor cell, dozens of different genes may be aberrant in structure or copy number, and hundreds or thousands of genes may be differentially expressed. A number of familial cancer genes with high-penetrance mutations have been identified, but the contribution of low-penetrance genetic variants or polymorphisms to the risk of sporadic cancer development remains unclear. Studies of the complex somatic genetic events that take place in the emerging cancer cell may aid the search for the more elusive germline variants that confer increased susceptibility. Insights into the molecular pathogenesis of cancer have provided new strategies for treatment, but a deeper understanding of this disease will require new statistical and computational approaches for analysis of the genetic and signaling networks that orchestrate individual cancer susceptibility and tumor behavior.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
